European Society for Medical Oncology Congress

The latest news from ESMO, including researcher interviews and physician perspective.


Meeting NewsPerspective

Atezolizumab combination extends survival for some patients with metastatic triple-negative breast cancer

October 20, 2018
MUNICH — The addition of atezolizumab to nab-paclitaxel conferred a modest but statistically significant PFS benefit among patients with…
Meeting NewsPerspective

Addition of palbociclib to fulvestrant extends OS among certain women with advanced breast cancer

October 20, 2018
MUNICH — The addition of palbociclib to fulvestrant appeared associated with a clinically meaningful improvement in OS among women with hormone…
Meeting NewsPerspective

Alpelisib prolongs PFS for PIK3CA-mutant advanced breast cancer

October 20, 2018
MUNICH — The addition of alpelisib to fulvestrant significantly extended PFS among patients with hormone receptor-positive, HER2-negative…
Meeting News

Women more likely to experience key side effects from chemotherapy for esophagogastric cancer

October 20, 2018
MUNICH — Women appeared more likely than men to experience certain side effects from first-line chemotherapy for esophagogastric cancer…
Meeting NewsPerspective

Psychosocial therapy reduces fear of disease progression among women with ovarian cancer

October 20, 2018
MUNICH — A psychological support intervention significantly reduced fear of progression among women with ovarian cancer, according to…
Meeting NewsPerspective

Shorter trastuzumab course cost-effective for early-stage breast cancer

October 20, 2018
MUNICH — A 6-month course of adjuvant trastuzumab appeared more cost-effective than standard 12-month treatment for women with HER2-positive…
Meeting News

Women, older patients with sarcoma more likely to use complementary medicine

October 19, 2018
MUNICH — The use of complementary and alternative medicine for sarcoma, gastrointestinal stromal tumors or desmoid tumors appeared more common…
Meeting NewsPerspective

Addition of chemotherapy to androgen deprivation reduces relapse risk among men with high-risk localized prostate cancer

October 19, 2018
MUNICH — The addition of four cycles of docetaxel-based chemotherapy to androgen deprivation therapy significantly reduced the risk for…
Meeting News

Most breast cancer-related tweets focus on awareness, patient experiences

October 19, 2018
MUNICH — The majority of breast cancer-related tweets focus on disease awareness and patients’ experiences rather than medical…
Meeting NewsPerspective

One in six premenopausal women with early breast cancer do not adhere to adjuvant tamoxifen

October 19, 2018
MUNICH — Approximately one in six premenopausal women with early-stage breast cancer failed to adequately adhere to adjuvant tamoxifen therapy…